StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SLS

SELLAS Life Sciences Group, Inc.

SLS Nasdaq Pharmaceutical Preparations EDGAR ↗
$11.22
+0.93 +9.04%

Key statistics

from XBRL data in SEC filings
Market cap
$2.09B
Revenue (TTM)
$0.00
Net income (TTM)
-$29.5M
EPS (TTM)
$-0.23
P/E ratio
Dividend yield
Free cash flow
-$28.4M
Cash
$107M
Total assets
$114M
Gross margin
52-week range
$1.39 – $15.88

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release); Other events Jul 27, 2026 8-K Director or officer change Jun 25, 2026 8-K Shareholder vote results Jun 18, 2026 8-K Other events Jun 2, 2026 8-K Results of operations (earnings release) May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Other events Mar 11, 2026 8-K Results of operations (earnings release); Other events Jan 8, 2026 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Other events Oct 27, 2025 8-K Entered a material agreement Oct 3, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 11, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Shareholder vote results Jun 18, 2025 8-K Changed accountants Jun 6, 2025 8-K Results of operations (earnings release) May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Entered a material agreement; Other events Jan 29, 2025 8-K Regulation FD disclosure Jan 23, 2025 8-K Director or officer change Jan 16, 2025 8-K Regulation FD disclosure Dec 10, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Entered a material agreement Oct 4, 2024 8-K Results of operations (earnings release) Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Entered a material agreement; Other events Aug 1, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Results of operations (earnings release) May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) Mar 28, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Other events Mar 28, 2024 8-K Entered a material agreement; Other events Mar 15, 2024